Bellerophon Therapeutics, Inc. Current Liabilities
Bellerophon Therapeutics, Inc. had Current Liabilities of $1.26 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-11-14
- 2023-09-30: Liabilities, Current $1.26M.
- 2023-06-30: Liabilities, Current $5.62M.
- 2022-12-31: Liabilities, Current $5.40M.
- 2022-09-30: Liabilities, Current $5.18M.
| Period end | Liabilities, Current |
|---|---|
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $5.62M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $5.40M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $5.18M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.45M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $5.57M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $5.05M 10-K · filed 2023-03-31 |
| 2021-09-30 | $5.13M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $6.23M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.09M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $10.43M 10-K · filed 2022-03-31 |
| 2020-09-30 | $8.99M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.58M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $6.78M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $7.58M 10-K · filed 2021-03-11 |
| 2019-09-30 | $6.98M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $6.71M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $7.26M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $7.54M 10-K · filed 2020-04-06 |
| 2018-09-30 | $9.07M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $9.04M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $8.40M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $7.08M 10-K · filed 2019-03-14 |
| 2017-09-30 | $6.41M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $5.49M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $6.06M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $6.50M 10-K · filed 2018-03-15 |
| 2016-09-30 | $4.79M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $6.21M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $7.32M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $8.07M 10-K · filed 2017-03-13 |
| 2015-09-30 | $8.64M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $11.15M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $12.79M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $10.45M 10-K · filed 2016-03-21 |